Skip to Main Content

Author Details

Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
2003
158
48
PMIDPaper TitleJournal TitlePublished Year
36749370Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance.Eur Radiol2023
37489505Prostatic stromal tumour of uncertain malignant potential treated with robotic-assisted radical prostatectomy: medium-term oncological and functional outcome of two cases.Ann R Coll Surg Engl2023
38011568Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.Proc Natl Acad Sci U S A2023
37554444The SWI/SNF complex member SMARCB1 supports lineage fidelity in kidney cancer.iScience2023
37485169Granulicatella adiacens Endocarditis of a Bioprosthetic Aortic Valve.Cureus2023
37284396Non-sustained Ventricular Tachycardia as a Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy.Cureus2023
34549873Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib.BJU Int2022
35676472The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.Nature2022
35731287The potential of hyperpolarised <sup>13</sup>C-MRI to target glycolytic tumour core in prostate cancer.Eur Radiol2022
35696280How and when should radiologists report T-staging on MRI in patients with prostate cancer?BJU Int2022
35358786Value of the capsular enhancement sign on dynamic contrast-enhanced prostate multiparametric MRI for the detection of extracapsular extension.Eur J Radiol2022
36539415Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression.Nat Commun2022
36505871The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract.Front Oncol2022
36170366Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.Sci Adv2022
35953766Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population.BMC Cancer2022
35953478Clonal diversification and histogenesis of malignant germ cell tumours.Nat Commun2022
35075123Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer.Nat Commun2022
35256616Author Correction: Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer.Nat Commun2022
35199583Integration of Prostate Biopsy Results with Pre-Biopsy Multiparametric Magnetic Resonance Imaging Findings Improves Local Staging of Prostate Cancer.Can Assoc Radiol J2022
35053497Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study.Cancers (Basel)2022
34962144Death by Chocolate: The Palliative Management of Dysphagia.J Palliat Med2022
35323939Elongin C (ELOC/TCEB1)-associated von Hippel-Lindau disease.Hum Mol Genet2022
32989229The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG).Br J Cancer2021
33774889Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?BJU Int2021
34936871Resolving the immune landscape of human prostate at a single-cell level in health and cancer.Cell Rep2021
34433962The mutational landscape of human somatic and germline cells.Nature2021
34699525Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.PLoS One2021
34794412The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.BMC Cancer2021
34062473Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naïve patients.Eur J Radiol2021
34162837Single cell derived mRNA signals across human kidney tumors.Nat Commun2021
33196886MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance.Eur Radiol2021
33403511Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer.Virchows Arch2021
33369077'Case of the Month' from Cambridge University, UK: managing intractable bleeding from a 375 cc prostate in an anti-coagulated patient.BJU Int2021
32830346Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity.Genes Chromosomes Cancer2021
31081564Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated <sup>13</sup> C and <sup>23</sup> Na endorectal coils.J Magn Reson Imaging2020
31636096Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans.Clin Cancer Res2020
31943436Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.Genes Chromosomes Cancer2020
33072331Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study.J Clin Urol2020
33004514Extensive heterogeneity in somatic mutation and selection in the human bladder.Science2020
32804543Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.JCO Clin Cancer Inform2020
32686200A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.Clin Endocrinol (Oxf)2020
32755355Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI.AJR Am J Roentgenol2020
32111235Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.Genome Med2020
32166495Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.Eur Radiol2020
32459716The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.Am J Surg Pathol2020
32479105Comparison of Likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.Br J Radiol2020
32450824Independence of HIF1a and androgen signaling pathways in prostate cancer.BMC Cancer2020
32123862Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133<sup>+</sup> cells in clear cell renal carcinoma.FASEB Bioadv2020
31306539Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.BJU Int2020
30499634Using prognosis to guide early detection and treatment selection in non-metastatic prostate cancer.BJU Int2019
  • 1 - 50 of 158

Recommended Authors

Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 5
Himisha Beltran
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 18
Jeffrey J Tosoian
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 8
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 12
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 6
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 13
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 9
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 6
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 23
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 22
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 7
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 11
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 9
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 16
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 17
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 12
David Clouston
Career Start Year 1995
Number of shared co-authors 10
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 10
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 18
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 29
Neil E Fleshner
University of Toronto
Career Start Year 1989
Number of shared co-authors 55
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 21
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 14
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 21
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 32
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 24
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 38
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 14

Collaborators

David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 57
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 52
Charlie E Massie
University of Cambridge
Co-authored papers 29
Ian G Mills
Queen's University Belfast
Co-authored papers 23
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 23
Hayley C Whitaker
University College London
Co-authored papers 22
Andy G Lynch
University of St Andrews
Co-authored papers 18
Alastair D Lamb
University of Oxford
Co-authored papers 15
Jonathan Kay
University College London
Co-authored papers 14
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 12
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 11
Helen J Ross
Mayo Clinic
Co-authored papers 10
Andrew N Priest
University of Cambridge
Co-authored papers 10
Thomas J Mitchell
University at Albany, State University of New York
Co-authored papers 10
Hayley J Luxton
University College London
Co-authored papers 8
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 8
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 8
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 8
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 7
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 6
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Freddie C Hamdy
University of Oxford
Co-authored papers 6
Inigo Martincorena
Wellcome Sanger Institute
Co-authored papers 6
Adam Butler
Wellcome Sanger Institute
Co-authored papers 6
Peter Van Loo
The Francis Crick Institute
Co-authored papers 6
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers 6
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 6
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 6
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 6
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 6
Release 1.2